DURHAM, N.C., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that Kenneth I. Moch, President and CEO of Chimerix, will present at the 16th Annual BIO CEO & Investor Conference on Monday, February 10, 2014 at 4:30pm EST at the Waldorf Astoria in New York City.
Help employers find you! Check out all the jobs and post your resume.
